Original Publication Date: 1 September, 2014
Publication / Source: International Journal of Endocrine Oncology
Authors: Wieneke Alexandra Buikhuisen, Margot Elisabeth Theresia Tesselaar, Marie-Louise Francijntje van Velthuysen et al
A total of 25% of neuroendocrine tumors originate in the lung. Still, typical and atypical carcinoids of the lung are rare, accounting for only 1–2% of all lung cancers. Distant metastases are infrequent, occurring in 2–14% of cases. The mainstay of treatment of local disease is surgery. In advanced disease there are no antiproliferative agents approved for carcinoids of the lung.